. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample. Neurobiol Aging. 2006 Sep;27(9):1202-11. Epub 2005 Aug 8 PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(76)
463 ± 218
pg/mL
ELISA;
Innotest;
Innogenetics
1991; McKhann et al., 1984
Aβ42
(CSF)
CTRL-
CNC
(39)
731 ± 278
pg/mL
ELISA;
Innotest;
Innogenetics
tau-p181
(CSF)
AD
(76)
87.1 ± 28.9
pg/mL
ELISA;
Innotest;
Innogenetics
1991; McKhann et al., 1984
tau-p181
(CSF)
CTRL-
CNC
(39)
51.8 ± 18.6
pg/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
AD
(76)
615 ± 362
pg/mL
ELISA;
Innotest;
Innogenetics
1991; McKhann et al., 1984
tau-total
(CSF)
CTRL-
CNC
(39)
249 ± 118
pg/mL
ELISA;
Innotest;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

Comments on this Paper

No Available Comments

Make a Comment

To make a comment you must login or register.